Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Moscow

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Future Approaches to Precision Oncology-Based Clinical TrialsArjun Mittra, Jeffrey A Moscow
Cell Biology International|May 25, 2010
Addressing the design of in vitro models for the investigation of microcystins: the essential role of transporter-mediated uptakeNoel R Monks, Jeffrey A Moscow
Cancer Biology & Therapy|November 25, 2010
Can an enzyme cofactor be a factor in malignant progression?Adam D Richardson, Jeffrey A Moscow
Journal of the National Cancer Institute|December 19, 2022
Dose optimization during drug development: whether and when to optimizeEdward L Korn, Jeffrey A Moscow, Boris Freidlin
Nature Reviews. Clinical Oncology|December 20, 2017
The evidence framework for precision cancer medicineJeffrey A Moscow, Tito Fojo, Richard L Schilsky
Oncotarget|September 11, 2018
Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugsTing-Hui Wu, Nagla Karim, Jeffrey A Moscow
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2003
Basolateral active uptake of nitrofurantoin in the CIT3 cell culture model of lactationPhillip M Gerk, Jeffrey A Moscow, Patrick J McNamara
Pediatric Hematology and Oncology|June 24, 2008
Spontaneous resolution of a single lesion of myeloid leukemia cutis in an infant: case report and discussionJohn A D'Orazio, Joseph F Pulliam, Jeffrey A Moscow
Toxicon : Official Journal of the International Society on Toxinology|December 1, 2009
Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibitionAbigail Daily, Noel R Monks, Markos Leggas, et al.
Molecular Cancer Research : MCR|August 26, 2004
Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cellsShuqian Liu, Arnold Stromberg, Hsin-Hsiung Tai, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Cancer Journal (Sudbury, Mass.)|July 24, 2019
Future Approaches to Precision Oncology-Based Clinical TrialsArjun Mittra, Jeffrey A Moscow
Cell Biology International|May 25, 2010
Addressing the design of in vitro models for the investigation of microcystins: the essential role of transporter-mediated uptakeNoel R Monks, Jeffrey A Moscow
Cancer Biology & Therapy|November 25, 2010
Can an enzyme cofactor be a factor in malignant progression?Adam D Richardson, Jeffrey A Moscow
Journal of the National Cancer Institute|December 19, 2022
Dose optimization during drug development: whether and when to optimizeEdward L Korn, Jeffrey A Moscow, Boris Freidlin
Nature Reviews. Clinical Oncology|December 20, 2017
The evidence framework for precision cancer medicineJeffrey A Moscow, Tito Fojo, Richard L Schilsky
Oncotarget|September 11, 2018
Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugsTing-Hui Wu, Nagla Karim, Jeffrey A Moscow
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2003
Basolateral active uptake of nitrofurantoin in the CIT3 cell culture model of lactationPhillip M Gerk, Jeffrey A Moscow, Patrick J McNamara
Pediatric Hematology and Oncology|June 24, 2008
Spontaneous resolution of a single lesion of myeloid leukemia cutis in an infant: case report and discussionJohn A D'Orazio, Joseph F Pulliam, Jeffrey A Moscow
Toxicon : Official Journal of the International Society on Toxinology|December 1, 2009
Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibitionAbigail Daily, Noel R Monks, Markos Leggas, et al.
Molecular Cancer Research : MCR|August 26, 2004
Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cellsShuqian Liu, Arnold Stromberg, Hsin-Hsiung Tai, et al.
Pageof 7